Live Biotherapeutic Products: Where Are We?

  • 1,768

    Total downloads

  • 12k

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 30 May 2024 | Manuscript Extension Submission Deadline 31 May 2024

Background

Live biotherapeutic products (LBPs) are a promising, newly emergent class of therapeutic agents that utilize live microorganisms, such as bacteria, viruses, or fungi, to prevent or treat various diseases. Depending on LBP type, disease target and route of administration, LBPs exert their therapeutic effects through various mechanisms in complex and manifold ways — via modulation of the gut microbiota, regulation of immune responses, production of antimicrobial substances, and enhancement of barrier functions in the body after engraftment. Clinical applications of LBPs include gastrointestinal disorders (e.g., inflammatory bowel disease [IBD] and irritable bowel syndrome [IBS]), metabolic disorders (e.g., obesity and diabetes), infectious diseases (e.g., recurrent Clostridioides difficile infection [rCDI]), mental health conditions (e.g., depression and anxiety), and certain cancers. Ongoing challenges include optimal standardization during LBP formulation (e.g., stability and viability of live microorganisms during manufacturing, storage, and delivery), establishing optimal dosing regimens, understanding the complex interactions between LBPs and tissue-specific human microbiota, and addressing potential safety signals following transplantation.

The regulatory landscape for LBPs is still evolving with the development of new guidelines outlining requirements for preclinical and clinical studies, manufacturing processes, quality control, and post-marketing surveillance. In 2012, the US Food and Drug Administration (FDA) published the first guidance for LBP development, which were defined as biological products that: 1) contain live organisms; 2) are applicable to the treatment, prevention or cure of a disease, and; 3) are not a vaccine. Eleven years later, the first two LBPs have been approved by the US FDA for commercialization.

This research topic aims to publish the latest advances in LBP development, clinical evaluation and outcomes assessment to ultimately improve LBP awareness and demonstrate how LBPs can revolutionize disease treatment.

Submission of original research involving clinical data, reviews and minireviews, methods, resources, and perspectives on future directions and challenges are welcome. Potential topics may include, but are not limited to:

• Exploring factors impacting regulatory decision-making and the status of US-, EU- and region-specific regulatory guidance regarding LBP use

• Developing improved approaches to LBP manufacturing and standardization

• Gaining a better appreciation for the diversity and complexity of LBP mechanisms of action

• Optimizing clinical trial methodology, data generation, biostatistics, and sequencing validation/standardization

• Evaluating real-world evidence generation and the development of biomarkers assessing LBP impact, disease risk and monitoring

• Exploring emerging therapy areas of interest, including reproductive and women’s health, rCDI, IBD, IBS, immuno-oncology, metabolic disease, liver disease, autism and the gut-brain axis

• Investigating novel aspects of LBP-based treatment modalities, including alignment on engraftment, decolonization, and antimicrobial resistance

• Probing unique perspectives on traditional drug development concepts and their application to LBPs

• Evaluating new approaches to health economics and outcomes assessments and patient perspectives on LBPs and the medical value of disease-specific unmet needs

• Integrating clinical evidence with medical value in the context of the investment landscape


The Topic Editor Ken Blount is employed by Ferring Pharmaceuticals. The Topic Editor Christine Lee received financial support from Ferring Pharmaceuticals, Seres Therapeutics, and Summit Therapeutics; and the Topic Editor Sahil Khanna received financial support from Ferring Pharmaceuticals, Seres Therapeutics, Vedanta, Finch and Pfizer. The other Topic Editors declare no competing interests with regard to the Research Topic subject.

Research Topic Research topic image

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Classification
  • Clinical Trial
  • Editorial
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Live biotherapeutic products, live microorganisms, human diseases, LBP formulation, manufacturing processes, quality control

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 12kTopic views
  • 7,749Article views
  • 1,768Article downloads
View impact